INBS - Intelligent Bio Solutions Inc

4.28
-0.110   -2.570%

Share volume: 56,297
Last Updated: 03-05-2026
Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies: -0.03%

PREVIOUS CLOSE
CHG
CHG%
$4.39
-0.11
-0.03%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
32%
Profitability 35%
Dept financing 40%
Liquidity 22%
Performance 30%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
-4.04%
1 Month
-31.30%
3 Months
502.82%
6 Months
160.18%
1 Year
84.48%
2 Year
-20.59%
Key data
Stock price
$4.28
P/E Ratio 
0.00
DAY RANGE
$4.10 - $4.38
EPS 
-$4.11
52 WEEK RANGE
$0.54 - $24.90
52 WEEK CHANGE
$76.86
MARKET CAP 
9.008 M
YIELD 
N/A
SHARES OUTSTANDING 
1.604 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
05-07-2025
BETA 
2.54
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$238,345
AVERAGE 30 VOLUME 
$133,164
Company detail
CEO: Harry Simeonidis
Region: US
Website: gbs.inc
Employees: 10
IPO year: 2020
Issue type: Common Stock
Market: XNAS
Industry: Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies
Sector: Manufacturing

GBS Inc. operates as a biosensor diagnostic technology company. It offers Saliva Glucose Biosensor that uses saliva to measure glucose non-invasively. The company was incorporated in 2016 and is headquartered in New York, New York.

Recent news